BioAtla, Inc. — Director's Dealing 2022

Feb 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2022-02-21

Reporting Person: WALDRON RICHARD A (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-21	Employee Stock Option (right to buy)	$6.75	A	115000	Acquired	2032-02-21	Common Stock (115000)	Direct

Footnotes

F1: The option vests over a period of four years, with 25% of the shares underlying the option vesting on February 21, 2023, the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting dates.